Skip to main content
Literatur
1.
Zurück zum Zitat Martínez MA, Inglada L, Ochoa C, Villagrasa JR (2007) Assessment of antibiotic prescription in acute urinary tract infections in adults. J Inf Secur 54:235–244 Martínez MA, Inglada L, Ochoa C, Villagrasa JR (2007) Assessment of antibiotic prescription in acute urinary tract infections in adults. J Inf Secur 54:235–244
2.
Zurück zum Zitat De Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I et al (2017) Executive summary of the diagnosis and treatment of urinary tract infection: guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin 35:314–320CrossRefPubMed De Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I et al (2017) Executive summary of the diagnosis and treatment of urinary tract infection: guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin 35:314–320CrossRefPubMed
3.
Zurück zum Zitat Schaeffer AJ, Nicolle LE (2016) Urinary tract infections in older men. N Engl J Med 374:562–571CrossRefPubMed Schaeffer AJ, Nicolle LE (2016) Urinary tract infections in older men. N Engl J Med 374:562–571CrossRefPubMed
4.
Zurück zum Zitat CLSI. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M 100, Wayne, PA: Clinical and Laboratory Standards Institute: 2018 CLSI. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M 100, Wayne, PA: Clinical and Laboratory Standards Institute: 2018
5.
Zurück zum Zitat The European Committee on Antimicrobial Susceptibility Testing (2018) Breakpoint tables for interpretation of MICs and zone diameters. Version 8:0 http://www.eucast.org The European Committee on Antimicrobial Susceptibility Testing (2018) Breakpoint tables for interpretation of MICs and zone diameters. Version 8:0 http://​www.​eucast.​org
6.
Zurück zum Zitat Delgado-Valverde M, Valiente Mendez A, Torres E, Almirante B, Gómez-Zorrilla S et al (2017) MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother 72:1478–1487PubMed Delgado-Valverde M, Valiente Mendez A, Torres E, Almirante B, Gómez-Zorrilla S et al (2017) MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother 72:1478–1487PubMed
7.
Zurück zum Zitat Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J (2013) Consequences of switching from a fixed 2:1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli. J Antimicrob Chemother 68:2636–2640CrossRefPubMed Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J (2013) Consequences of switching from a fixed 2:1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli. J Antimicrob Chemother 68:2636–2640CrossRefPubMed
8.
Zurück zum Zitat Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society of Microbiology and Infectious Diseases. Clin Pract Guide 52:103–120 Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society of Microbiology and Infectious Diseases. Clin Pract Guide 52:103–120
9.
Zurück zum Zitat Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, Domínguez-Gil González M, Gómez-Nieto A et al (2012) Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)- producing enterobacteria. Int J Clin Pract 66:891–896CrossRefPubMed Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, Domínguez-Gil González M, Gómez-Nieto A et al (2012) Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)- producing enterobacteria. Int J Clin Pract 66:891–896CrossRefPubMed
10.
Zurück zum Zitat Martinelli R, Da Silva Lopes A, De Oliveira MM, Rocha H (1981) Amoxicillin-clavulanic acid in treatment of urinary tract infection due to Gram-negative bacteria resistant to penicillin. Antimicrob Agents and Chemother 20:800–802CrossRef Martinelli R, Da Silva Lopes A, De Oliveira MM, Rocha H (1981) Amoxicillin-clavulanic acid in treatment of urinary tract infection due to Gram-negative bacteria resistant to penicillin. Antimicrob Agents and Chemother 20:800–802CrossRef
Metadaten
Titel
Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men
verfasst von
Amaia Aguirre-Quiñonero
M. C. Lecaroz Agara
A. Canut Blasco
Publikationsdatum
23.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3307-6

Weitere Artikel der Ausgabe 9/2018

European Journal of Clinical Microbiology & Infectious Diseases 9/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.